Welcome to our dedicated page for AEGON LTD. SEC filings (Ticker: AEFC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on AEGON LTD.'s stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into AEGON LTD.'s regulatory disclosures and financial reporting.
Aegon Ltd (AEG) has published the agenda for an Extraordinary General Meeting of Shareholders on October 8, 2026, to seek shareholder approval for its redomiciliation to the US, following plans announced at its December 2025 Capital Markets Day. A Shareholder Circular dated August 26, 2026, details the proposed redomiciliation, future organizational and governance documents, and an Omnibus Incentive Plan.
The EGM will be held virtually, with a livestream and full instructions for registration, participation, and voting available on Aegon’s dedicated EGM webpage. Aegon describes itself as an international financial services holding company focused on building a leading US life insurance, annuity, and retirement group, and notes an April 15, 2026 agreement to sell its UK insurance platform, expected to complete around the end of 2026.
Aegon Ltd. (AEG) has filed a registration statement on Form F-4 with the U.S. SEC, serving as a Shareholder Circular for an upcoming Extraordinary General Meeting expected on October 8, 2026. This filing is a key step in Aegon’s planned redomiciliation to the United States through domestication and continuation as a Delaware corporation.
The circular covers all proposals related to the redomiciliation, including new organizational and governance documents and an Omnibus Incentive Plan. It also discloses a Voting Undertaking Agreement under which Vereniging Aegon, holding approximately 18.4% of currently exercisable voting rights, has agreed to vote in favor of the redomiciliation and incentive plan proposals.
Aegon Ltd. (AEG) reports that on August 25, 2026 it entered into a voting undertaking agreement with Vereniging Aegon, its largest shareholder holding approximately 18.4% of currently exercisable voting rights. The agreement relates to Aegon’s intended cross-border continuation (redomiciliation) from Bermuda to Delaware.
Under the Voting Undertaking, Vereniging Aegon has agreed to vote in favor of the Redomiciliation and the adoption of the Aegon Ltd. 2027 Omnibus Incentive Plan at a special general meeting of shareholders expected on October 8, 2026. Aegon also plans to file a Form F-4 registration statement including a Proxy Statement/Prospectus for shareholders regarding the proposed Redomiciliation.
AEGON LTD. (AEG) received an amended Schedule 13D from Vereniging Aegon, which reports beneficial ownership of 264,665,203 Common Shares, representing 18.01% of the Common Shares outstanding. Including its 327,885,200 Common Shares B, Vereniging Aegon can vote 32.64% of the issuer’s total voting power.
The reporting person entered into a 2026 Voting Undertaking with Aegon Ltd. on August 25, 2026, agreeing to vote all its Common Shares and Common Shares B in favor of resolutions at an extraordinary general meeting currently anticipated for October 8, 2026. These resolutions include the proposed redomiciliation from Bermuda to Delaware via continuation into Transamerica Inc., adoption of interim bye-laws, termination of the Voting Rights Agreement and related agreements, approval of Transamerica Inc. organizational documents, a Conversion, a 2027 Omnibus Incentive Plan, and a possible adjournment proposal.
Subject to completion of the VA Split, Aegon Ltd. will acquire 327,885,200 Common Shares B from Vereniging Aegon and issue 8,197,130 Common Shares on a 40-for-1 basis as consideration in the Conversion. After this, no Common Shares B will remain outstanding, and the 1983 Amended Merger Agreement, Voting Rights Agreement, and related Call Option will terminate when the Interim Bye-Laws take effect.
Aegon Ltd. (AEG) has increased its second-half 2026 share buyback program by EUR 150 million, bringing the total program size to EUR 350 million, up from EUR 200 million. This increase aligns with Aegon’s objective to reduce Cash Capital at Holding to around EUR 1.0 billion by year-end 2026.
The original EUR 200 million program began on July 1, 2026, and Aegon has so far repurchased EUR 57 million of shares, about 28% of the initial program. The expanded program is expected to run until December 23, 2026, barring unforeseen circumstances, with shares intended to be cancelled after repurchase.
Aegon’s largest shareholder, Vereniging Aegon, which holds about 18.4% of currently exercisable voting rights, will participate pro-rata. This corresponds to EUR 26 million of the additional EUR 150 million and EUR 63 million across the full EUR 350 million program. Purchases, including those from Vereniging Aegon, will be executed by a third party at prices based on the daily volume-weighted average price on Euronext Amsterdam and in compliance with the EU Market Abuse Regulation and existing shareholder authorities.
Aegon Ltd. (AEG) reported solid first-half 2026 results while advancing its shift to a US‑focused life and retirement group and preparing redomiciliation to the US. Net result was EUR 608 million, broadly flat year-on-year, while operating result rose 9% to EUR 804 million.
Operating capital generation increased 27% to EUR 416 million, supporting EUR 392 million of free cash flow. Transamerica delivered strong growth, including Individual Life new sales up 54% and World Financial Group agents above 100,000. Asset Management assets under management grew 22% to EUR 390.4 billion, helped by the transfer of Transamerica Asset Management.
Aegon announced an interim dividend of EUR 0.21 per share, up 11%, and increased its ongoing 2026 share buyback to EUR 350 million. Valuation equity rose to EUR 14.0 billion, while the Group solvency ratio decreased to 169% after capital actions and loss of eligibility for certain subordinated instruments, with key US and UK capital ratios still well above operating targets.
Aegon Ltd (AEG) reports a planned Chief Financial Officer transition linked to moving its head office and legal seat to the United States. The company has agreed with CFO Duncan Russell that he will step down and leave in April 2027, and has started searching for his successor.
CEO Lard Friese and Duncan Russell both emphasize Russell’s role in Aegon’s transformation and his commitment to an orderly handover. Aegon states it will provide further updates as appropriate while continuing its strategy to become a leading US life insurance, annuity, and retirement group.
Aegon Ltd. (AEG) reported solid first half 2026 results while advancing its strategic shift toward a US-centered life, annuity, and retirement group. Operating result rose 9% to EUR 804 million, and net result was broadly stable at EUR 608 million. Operating capital generation increased 27% to EUR 416 million, supporting EUR 392 million of free cash flow.
Transamerica drove growth: new Individual Life sales rose 54%, WFG licensed agents exceeded 100,000, and Retirement Plans assets under administration grew 12% with improved returns. International results were led by Brazil and Transamerica Life Bermuda, while Asset Management benefited from higher Assets under Management of EUR 390 billion, up 22%.
Capital remained strong but moderated, with the Group solvency ratio at 169% and US RBC at 420%. Aegon announced an 11% higher interim dividend of EUR 0.21 per share and expanded its 2026 second-half share buyback to EUR 350 million. The company is progressing with its planned redomiciliation to the US and the announced sale of Aegon UK to Standard Life.
AEGON LTD. director Mark Alan Ellman reported acquiring 32 Common Shares as a compensation-related award. The shares were granted as dividend equivalent shares tied to his outstanding equity awards, rather than through an open-market purchase. Following this award, he directly holds 15,705 Common Shares.
Boeren Leni reported acquisition or exercise transactions in this Form 4 filing.
AEGON LTD. director Leni Boeren received an award of 21 Common Shares on July 6, 2026 as dividend equivalent shares tied to her outstanding equity awards. The shares were granted at $0.00 per share, bringing her direct holdings to 4,181 Common Shares.